HomeLab TestHER2
Overview
HER2 (Human Epidermal growth factor Receptor 2) is a protein that can promote the growth of cancer cells. In certain cancers, particularly breast cancer, the HER2 gene can be amplified, leading to an overexpression of the HER2 pro...
Risk Assessment
-
HER2-Positive Breast Cancer:
- Tends to be more aggressive and fast-growing.
- Higher risk of recurrence.
- Can be treated with HER2-targeted therapies (e.g., trastuzumab, pertuzumab, lapatinib)....
Normal Range and Interpretation
Normal Range and Interpretation
- Normal (HER2-Negative):
- IHC score of 0 or 1+, or FISH/ISH showing no gene amplification.
- Indicates that the HER2 gene is not overexpressed or amplified, and the canc...
Normal Range and Interpretation
Normal Range and Interpretation
- Normal (HER2-Negative):
- IHC score of 0 or 1+, or FISH/ISH showing no gene amplification.
- Indicates that the HER2 gene is not overexpressed or amplified, and the canc...
Sample Type
Sample Type
- Tissue Sample: The most common sample type is a tissue biopsy from the tumor. This can be taken during surgery, a core needle biopsy, or a fine needle aspiration.
- Blood Sample: ...
Frequently Asked Questions
1. **What is the HER2 test?**
2. **Why is the HER2 test important?**
3. **How is the HER2 test performed?**
4. **What do the results mean?**
5. **What if the HER2 test results are inconclusive?**
6. **Can HER2 status change over time?**
7. **Who should get the HER2 test?**
8. **How does HER2 status influence treatment?**
9. **Are there side effects of HER2-targeted therapies?**
10. **Is HER2 testing covered by insurance?**
11. **What should I ask my doctor about my HER2 status?**
11. What should I ask my doctor about my HER2 status?
Report in 12 hours
Booked 0 times
HER2
Subtitle: Evaluation of HER2 Protein Expression in Cancer Cells
৳4000
Sample Type:
blood
Fasting Required:
No
Description
The HER2 test evaluates the expression of the HER2 protein in cancer cells, primarily used in breast cancer diagnosis and treatment. HER2-positive breast cancer tends to grow more aggressively and may respond differently to treatment than HER2-negative breast cancer. The test results help healthcare providers determine the most appropriate treatment approach, such as targeted therapies that specifically inhibit the HER2 protein.
Covid Safety
Assured
Free Report
Counselling